UNITED KINGDOM – Unilever has ruled out increasing its £50 billion (US$68.3 billion) bid for GlaxoSmithKline’s consumer health unit after the pharma giant turned down the latest of three approaches…
Read MoreUnilever backs down on US$68.3 billion bid for GSK’s consumer health arm
